This paper aims to explore the main challenges facing the pharmaceutical industry today, as well as the potential opportunities offered by emerging Industry 4.0 technologies that can help address these challenges. To this end, a systematic literature review (SLR) based on a search with the keywords "Pharma" and "Industry 4.0" for identification, selection, and evaluation of the published research in this area, was performed. Thus, following this approach, two main questions were attempted to be answered: (i) "What is the As-Is situation that characterize the today's pharmaceutical production"; and, (ii) "How technological perspective presents itself as a possible To-Be situation by the use of I4.0 concepts". The key contribution of this research lays in the exploration of different obstacles in the current way how pharma is operating and what concepts from Industry 4.0 are in place to overcome them. The conclusion shows that the special situation in pharma due to its strong regulation by external authorities needs special ways of process design.
Pharmaceutical production typically focuses on individual drug types for each production line, which limits flexibility. However, the emergence of Industry 4.0 technologies presents new opportunities for more adaptable and customized manufacturing processes. Despite this promise, the development of innovative design techniques for pharmaceutical production equipment remains incomplete. Manufacturers encounter challenges due to rapid innovation cycles while adhering to stringent Good Manufacturing Practice (GMP) standards. Our research addresses this issue by introducing an information model that organizes the design, development, and testing of pharmaceutical manufacturing equipment. This model is based on an exploratory review of 176 articles concerning design principles in regulated industries and integrates concepts from Axiomatic Design, Quality by Design, Model-Based Systems Engineering, and the V-Model framework. Further refinement was achieved through insights from 10 industry experts. The resultant workflow-based information model can be implemented as software to enhance engineering and project management. This research offers a structured framework that enables pharmaceutical equipment manufacturers and users to collaboratively develop solutions in an iterative manner, effectively closing the gap between industry needs and systematic design methodologies.
The development of personalized drugs introduces new uncertainties and risks in production machinery design, which can be mitigated through structured workflows. As the commonly used V-Model approach has limitations in dealing with complex multi-domain problems, it is essential to address traceability and relationships between requirements and solutions in a regulated environment to ensure product quality. This study focuses on the conceptual design phase and develops a design methodology called the Case-based Axiomatic Design Assistant (CADA) to address this type of problem. It takes, as a starting point, Axiomatic Design (AD), due to its simplicity and graphical tools for quality evaluation, and Case-Based Reasoning (CBR), due to its capacity to integrate data structures and continuously improve. This combination is put into practice through a visual assistant that utilizes a knowledge graph to represent design elements comprehensively. This article describes the development, implementation, and testing process of CADA, which includes examples of the conceptual design for pharmaceutical manufacturing. The proposed CADA method facilitates systematic requirements analysis, structured reasoning, and solution evaluation, and overcomes the limitations of previous methodologies. It represents a novel approach with an intuitive workflow and advanced graphical capabilities, exemplified in the context of a conceptual design for pharmaceutical manufacturing. The inclusion of intrinsic data labeling capabilities and inference visualization enhances its relevance.
Modern custom machine construction and automation projects face pressure to shorten innovation cycles, reduce durations, and manage growing system complexity. Traditional methods like Waterfall and V-Model have limits where end-to-end data traceability is vital throughout the product life cycle. This study introduces the implementation of a web application that incorporates a model-based design approach to assess its applicability and effectiveness in conceptual design scenarios. At the heart of this approach is the Case-Based Axiomatic Design Assistant (CADA), which utilizes Axiomatic Design principles to break down complex tasks into structured, analyzable sub-concepts. It also incorporates Case-Based Reasoning (CBR) to systematically store and reuse design knowledge. The effectiveness of the visual assistant was evaluated through expert-led assessments across different fields. The results revealed a significant reduction in design effort when utilising prior knowledge, thus validating both the efficiency of CADA as a model and the effectiveness of its implementation within a user-centric application, highlighting its collaborative features. The findings support this approach as a scalable solution for enhancing conceptual design quality, facilitating knowledge reuse, and promoting agile development.